Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Riching KM"'
Autor:
Nishiguchi G; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Caine EA; Promega Corporation, 5430 East Cheryl Drive, Madison, Wisconsin 53711, United States., McGowan K; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Shi Z; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Aggarwal A; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Mayasundari A; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Price J; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Yang L; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Li Y; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Fu X; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Mascibroda LG; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Das S; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Daniels DL; Foghorn Therapeutics Inc, 500 Technology Square, Suite 700, Cambridge, Massachusetts 02139, United States., Urh M; Promega Corporation, 5430 East Cheryl Drive, Madison, Wisconsin 53711, United States., Klco JM; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States., Riching KM; Promega Corporation, 5430 East Cheryl Drive, Madison, Wisconsin 53711, United States., Rankovic Z; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Tennessee 38105, United States.; Center for Protein Degradation, The Institute of Cancer Research, London, 15 Cotswold Road, SuttonSM2 5NG, United Kingdom.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Sep 12; Vol. 15 (10), pp. 1692-1698. Date of Electronic Publication: 2024 Sep 12 (Print Publication: 2024).
Autor:
Nishiguchi G; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Mascibroda LG; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Young SM; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Caine EA; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA., Abdelhamed S; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Kooijman JJ; Oncolines B.V., Kloosterstraat 9, 5349 AB, Oss, The Netherlands., Miller DJ; Department of Structural Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Das S; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., McGowan K; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Mayasundari A; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Shi Z; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Barajas JM; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Hiltenbrand R; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Aggarwal A; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Chang Y; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Mishra V; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Narina S; Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Thomas M; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Loughran AJ; Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Kalathur R; Department of Structural Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Yu K; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Zhou S; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Wang X; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., High AA; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Peng J; Department of Structural Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.; Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Pruett-Miller SM; Center for Advanced Genome Engineering, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA.; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, Memphis, TN, 38105, USA., Daniels DL; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA., Urh M; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA., Shelat AA; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA., Riching KM; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA., Zaman GJR; Oncolines B.V., Kloosterstraat 9, 5349 AB, Oss, The Netherlands., Fischer M; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. marcus.fischer@stjude.org., Klco JM; Department of Pathology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. jeffery.klco@stjude.org., Rankovic Z; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN, 38105, USA. zoran.rankovic@stjude.org.
Publikováno v:
Nature communications [Nat Commun] 2024 Jan 16; Vol. 15 (1), pp. 482. Date of Electronic Publication: 2024 Jan 16.
Autor:
Ma HL; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Bizet M; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Soares Da Costa C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Murisier F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., de Bony EJ; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Wang MK; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Yoshimi A; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Lin KT; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA., Riching KM; Promega Corporation, Madison, WI 53711, USA., Wang X; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Beckman JI; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Arya S; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Droin N; Université Paris-Saclay, INSERM U1287, and Department of Hematology, Gustave Roussy Cancer Center, Villejuif 94800, France., Calonne E; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Hassabi B; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Zhang QY; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Li A; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Putmans P; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Malbec L; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Hubert C; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Lan J; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Mies F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Yang Y; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China., Solary E; Université Paris-Saclay, INSERM U1287, and Department of Hematology, Gustave Roussy Cancer Center, Villejuif 94800, France., Daniels DL; Promega Corporation, Madison, WI 53711, USA., Gupta YK; Greehey Children's Cancer Research Institute, Department of Biochemistry and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Deplus R; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium., Abdel-Wahab O; Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Yang YG; CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics and Chinese Academy of Sciences, China National Center for Bioinformation, Beijing 100101, China. Electronic address: ygyang@big.ac.cn., Fuks F; Laboratory of Cancer Epigenetics, Faculty of Medicine, ULB-Cancer Research Center (U-CRC), Université libre de Bruxelles (ULB), Institut Jules Bordet, Brussels 1070, Belgium. Electronic address: francois.fuks@ulb.be.
Publikováno v:
Molecular cell [Mol Cell] 2023 Dec 07; Vol. 83 (23), pp. 4239-4254.e10.
Autor:
Crummy EK; Promega Corporation, Madison, WI, United States. Electronic address: ellen.crummy@promega.com., Caine EA; Promega Corporation, Madison, WI, United States., Mikheil D; Promega Corporation, Madison, WI, United States., Corona C; Promega Biosciences Incorporated, San Luis Obispo, CA, United States., Riching KM; Promega Corporation, Madison, WI, United States., Hosfield C; Promega Corporation, Madison, WI, United States., Urh M; Promega Corporation, Madison, WI, United States.
Publikováno v:
Methods in enzymology [Methods Enzymol] 2023; Vol. 681, pp. 81-113. Date of Electronic Publication: 2022 Dec 12.
Autor:
Riching KM; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA. marjeta.urh@promega.com., Caine EA; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA. marjeta.urh@promega.com., Urh M; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA. marjeta.urh@promega.com., Daniels DL; Promega Corporation, 5430 East Cheryl Drive, Madison, WI, 53711, USA. marjeta.urh@promega.com.
Publikováno v:
Chemical Society reviews [Chem Soc Rev] 2022 Jul 18; Vol. 51 (14), pp. 6210-6221. Date of Electronic Publication: 2022 Jul 18.
Autor:
Bai N; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA. Electronic address: nbai@amgen.com., Riching KM; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA. Electronic address: Kristin.Riching@promega.com., Makaju A; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Wu H; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Acker TM; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Ou SC; Discovery Attribute Science, Amgen Research, Thousand Oaks, California, USA., Zhang Y; Oncology, Amgen Research, Thousand Oaks, California, USA., Shen X; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Bulloch DN; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Rui H; Discovery Attribute Science, Amgen Research, Thousand Oaks, California, USA., Gibson BW; Discovery Attribute Science, Amgen Research, South San Francisco, California, USA., Daniels DL; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA., Urh M; Research and Development Department, Promega Corporation, Madison, Wisconsin, USA., Rock BM; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA., Humphreys SC; Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California, USA. Electronic address: shumph01@amgen.com.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2022 Apr; Vol. 298 (4), pp. 101653. Date of Electronic Publication: 2022 Jan 29.
Autor:
Imaide S; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK.; Discovery Technology Research Laboratories, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Riching KM; Promega Corporation, Madison, WI, USA., Makukhin N; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Vetma V; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Whitworth C; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Hughes SJ; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK.; Amphista Therapeutics Ltd., Newhouse, UK., Trainor N; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Mahan SD; Promega Corporation, Madison, WI, USA., Murphy N; Promega Corporation, Madison, WI, USA., Cowan AD; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Chan KH; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK.; GlaxoSmithKline R&D, Stevenage, UK., Craigon C; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK., Testa A; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK.; Amphista Therapeutics Ltd., Newhouse, UK., Maniaci C; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK.; School of Natural and Environmental Sciences, Chemistry, Newcastle University, Newcastle upon Tyne, UK., Urh M; Promega Corporation, Madison, WI, USA., Daniels DL; Promega Corporation, Madison, WI, USA. danette.daniels@promega.com., Ciulli A; Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, James Black Centre, Dundee, UK. a.ciulli@dundee.ac.uk.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2021 Nov; Vol. 17 (11), pp. 1157-1167. Date of Electronic Publication: 2021 Oct 21.
Autor:
Jiang B; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Gao Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Lu W; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Kaltheuner IH; Institute of Structural Biology, University of Bonn, Bonn, Germany., Dries R; Department of Hematology and Oncology, Boston University, Boston, MA, USA.; Department of Computational Medicine, Boston University, Boston, MA, USA., Kalocsay M; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Berberich MJ; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Jiang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., You I; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Kwiatkowski N; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Riching KM; Promega Corporation, Madison, WI, USA., Daniels DL; Promega Corporation, Madison, WI, USA., Sorger PK; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA., Geyer M; Institute of Structural Biology, University of Bonn, Bonn, Germany., Zhang T; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. tinghu_zhang@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. tinghu_zhang@dfci.harvard.edu., Gray NS; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. nathanael_gray@dfci.harvard.edu.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2021 Jun; Vol. 17 (6), pp. 675-683. Date of Electronic Publication: 2021 Mar 22.
Autor:
Riching KM; Promega Corporation, Madison, WI, USA., Schwinn MK; Promega Corporation, Madison, WI, USA., Vasta JD; Promega Corporation, Madison, WI, USA., Robers MB; Promega Corporation, Madison, WI, USA., Machleidt T; Promega Corporation, Madison, WI, USA., Urh M; Promega Corporation, Madison, WI, USA., Daniels DL; Promega Corporation, Madison, WI, USA.
Publikováno v:
SLAS discovery : advancing life sciences R & D [SLAS Discov] 2021 Apr; Vol. 26 (4), pp. 560-569. Date of Electronic Publication: 2020 Nov 16.
Autor:
Mahan SD; Promega Corporation, Fitchburg, WI, USA., Riching KM; Promega Corporation, Fitchburg, WI, USA., Urh M; Promega Corporation, Fitchburg, WI, USA., Daniels DL; Promega Corporation, Fitchburg, WI, USA. danette.daniels@promega.com.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2365, pp. 151-171.